The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast
CONCLUSIONS: Taken together, our study implicates CXCL1 as a critical role in ERBC growth and metastasis via crosstalk with fibroblast and cotargeting CXCR1/2 and CDK4/6 could potentially overcome endocrine resistant breast cancer.PMID:38393465 | DOI:10.1007/s11033-023-09119-4
Source: Mol Biol Cell - Category: Molecular Biology Authors: Sneha Pandithar Daniel Galke Ahone Akume Artem Belyakov Dominick Lomonaco Amirah A Guerra Jay Park Olivia Reff Kideok Jin Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Molecular Biology | Study